Model Based Integrated Design of Pharmaceutical Drug Substance and Drug Product Processes I

This session seeks contributions where modeling-aided approaches as well as optimization techniques have been applied for decision making in the design and development of pharmaceutical intermediates, drug substances, and/or drug products. Modeling research including CFD, DEM, FEM, Monte Carlo, Population balance, thermodynamic, kinetic or other approaches are welcome. Authors are encouraged to highlight integration to upstream and downstream operations as well as Quality by Design considerations. Authors from both drug substance and drug product sides of the business are encouraged to submit an abstract.